Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
December 4th, 2017
8.5K views
This protocol describes the complete decellularization of human myocardium while preserving its extracellular matrix components. Further processing of the extracellular matrix results in the production of microparticles and a cytoprotective self-assembling hydrogel.
Overview
This protocol outlines the decellularization of human myocardium, preserving extracellular matrix components. It enables the production of microparticles and a cytoprotective hydrogel for cell-based assays.
Key Study Components
Area of Science
- Cardiac tissue engineering
- Extracellular matrix research
- Hydrogel applications
Background
- Understanding the role of extracellular matrix in cardiac health.
- Importance of cell behavior in response to matrix cues.
- Potential therapeutic applications for myocardial infarction.
- Need for large-scale in vitro and in vivo experiments.
Purpose of Study
- To process cardiac extracellular matrix into a usable hydrogel.
- To investigate the effects of the matrix on cell behavior.
- To facilitate large-scale experiments in cardiac research.
Methods Used
- Decellularization of human myocardium.
- Preparation of myocardium cubes for processing.
- Production of microparticles from the extracellular matrix.
- Creation of a cytoprotective self-assembling hydrogel.
Main Results
- Successful preservation of extracellular matrix components.
- Production of hydrogel suitable for cell-based assays.
- Demonstrated potential for therapeutic applications.
- Facilitated large-scale experimental setups.
Conclusions
- The method allows for effective study of cardiac extracellular matrix.
- Hydrogel provides essential survival cues for cells.
- This technique can advance research in cardiac therapies.
Frequently Asked Questions
What is the main goal of this protocol?
The main goal is to process cardiac extracellular matrix into a hydrogel for studying its effects on cell behavior.
How does this technique benefit cardiac research?
It facilitates large-scale experiments and helps answer key questions about extracellular matrix influence on cells.
What are the applications of the produced hydrogel?
The hydrogel can be used in various cell-based assays and has potential therapeutic applications for myocardial infarction.
What is the significance of preserving extracellular matrix components?
Preserving these components is crucial for maintaining the biological functions and cues necessary for cell survival and behavior.
What initial steps are involved in the experiment?
The initial steps include removing fat tissue and cutting the myocardium into small cubes for processing.
Can this method be applied in vivo?
Yes, the technique is designed to facilitate both in vitro and in vivo experiments.
Executive Industry Relevance
This protocol enables the production of human-derived cardiac extracellular matrix hydrogels and microparticles, providing a tissue-specific microenvironment for studying cell-matrix interactions in cardiac regeneration research. By preserving key biomolecules such as collagen, elastin, and glycosaminoglycans while removing cellular material, the method supports physiologically relevant in vitro and in vivo models. This approach addresses the lack of tissue-specific biological activity in commercial ECM products, offering a scalable source for mechanistic de-risking in cardiac therapeutic development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of cardiac extracellular matrix effects on pluripotent stem cell differentiation toward cardiomyocyte-like phenotypes.
- Operational Value: Provides a consistent, human-derived matrix substrate for functional target validation in cardiac pathways.
Screening & Assay Development
- Scientific Value: Generates standardized cardiac ECM microparticles and hydrogels suitable for high-throughput cell-based assays under ischemic conditions.
- Operational Value: Supports reproducible preparation of bioactive matrices for assessing compound effects on cell viability and metabolic activity.
Translational & Preclinical Research
- Scientific Value: Offers a disease-relevant system to evaluate matrix-mediated survival cues in models of myocardial infarction.
- Operational Value: Facilitates continuity from discovery to preclinical validation by providing implantable hydrogel formats with preserved bioactivity.
Pipeline & Workflow Integration
The method fits within the discovery continuum, supporting early target validation through matrix-dependent phenotypic screening and enabling translational progression via preclinical testing of ECM-based therapeutics.
- Discovery Biology: Supports hypothesis testing on how cardiac extracellular matrix influences stem cell fate and cell survival in ischemic environments.
- Screening: Delivers quantitative outputs such as metabolic activity and viability metrics for evaluating cellular responses to matrix cues.
- Analytics: Enables measurement of ECM composition (collagen, elastin, glycosaminoglycans) and DNA removal efficiency to assess matrix quality.
- Translational Research: Connects to preclinical work by providing implantable hydrogels that retain bioactive properties for regenerative applications.
- Enterprise Reuse: Establishes a scalable, standardized process for generating patient-relevant cardiac ECM materials across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by providing a human cardiac matrix model that reduces mechanistic ambiguity in target validation.
- Operational Value: Ensures reproducibility through standardized decellularization, pulverization, and hydrogel reassembly steps.
- Strategic Value: Improves go/no-go decisions by enabling early assessment of matrix-dependent cellular responses in disease-relevant contexts.
- Portfolio Impact: Supports risk-adjusted advancement of cardiac regenerative candidates by validating microenvironmental effects prior to costly in vivo studies.
Implementation Considerations
- Requires expertise in tissue handling, decellularization, and hydrogel preparation.
- Dependent on access to sterile laboratory equipment including cryostat, lyophilizer, and milling apparatus.
- Necessitates standardized protocols for tissue sourcing, washing, and pepsin digestion to ensure batch consistency.
- Involves adaptation considerations when applying the matrix to different cardiac cell types or species.
- Limited by the availability of human cardiac tissue and the need for aseptic processing to prevent contamination.
Biopharma FAQs
Why is DNA removal critical for cardiac extracellular matrix hydrogels?
Complete DNA removal minimizes immunogenic risks and ensures that observed cellular responses are due to matrix components rather than residual nucleic acids, which is essential for reliable target validation in cardiac regeneration studies.
How does pepsin digestion enable hydrogel self-assembly from cardiac ECM powder?
Pepsin digestion solubilizes the lyophilized cardiac extracellular matrix powder into a fluid state that, upon neutralization, undergoes self-assembly into a hydrogel at physiological temperatures, preserving bioactivity for cell-based assays.
What quantitative measurements confirm preservation of key extracellular matrix components?
Assays for collagen, elastin, and glycosaminoglycans demonstrate better preservation compared to SDS-only decellularization, indicating maintained structural and functional matrix properties critical for phenotypic screening.
Why are replication requirements important for cardiac ECM hydrogel studies?
Replication ensures consistency in matrix preparation across batches, which is vital for cross-functional collaboration and reliable comparison of drug effects in preclinical cardiac models.
What statistical analysis is needed before implementing cardiac ECM hydrogels in screening workflows?
Comparative analysis of cell viability, metabolic activity, and differentiation markers under ischemic versus standard conditions is required to establish significant matrix-mediated effects for go/no-go decisions in target validation pipelines.
Chapters in this video
0:05
Title
0:43
Sectioning Human Myocardium into Slices
2:27
Decellularization of Human Myocardium Slices
4:20
Processing the Decellularized cECM to a Powder
5:50
Enzyme-based Homogenization of cECM Micro-particles
6:56
Results: Effective Removal of Cellular Material Enhances Analysis
8:10
Conclusion
